Research and analysis

COVID-19: PHE laboratory assessments of molecular tests

PHE has undertaken rapid assessments of commercially provided diagnostic tests for SARS-CoV-2 nucleic acid detection with further evaluations ongoing.

Documents

Rapid assessment: BGI Real-Time Fluorescent RT-PCR kit for detecting 2019-nCoV

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Biomerieux ARGENE® SARS-COV-2 R-GENE® real-time detection kit

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: careGENE N-CoV RT-PCR Kit

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: COVID-19 Plus RealAmp kit

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: GenMark ePlex SARS-CoV-2 test

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment of selected commercial molecular diagnostic tests for the laboratory detection of COVID-19 infections

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: ViaSure SARS-CoV-2 Real Time PCR detection Kit

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Seegene ‘Allplex 2019-nCoV’ assay for the detection of SARS-CoV-2 (COVID-19)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Roche Ltd Coronavirus LightMix® Modular SARS and Wuhan CoV E-gene assay

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Randox Extended Coronavirus Multiplex Array assay

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Novacyt Primerdesign Coronavirus (COVID-19) genesig® Real-Time PCR assay

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Liferiver Novel Coronavirus Real Time Multiplex RT-PCR Kit

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Genetic Signatures EasyScreen™ SARS-CoV-2 Detection Kit

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Genetic PCR solutions CoVID-19 dtec-RT-qPCR Test

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: GeneFirst Novel Coronavirus (COVID-19) Real-Time PCR assay

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: AusDiagnostics Coronavirus Typing assay for the detection of SARS-CoV-2 (COVID-19)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Rapid assessment: Altona RealStar RT-PCR Kit 1.0. assay for detection of SARS-CoV-2 (COVID-19)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Public Health England (PHE) has undertaken rapid assessments of commercially provided diagnostic tests for SARS-CoV-2 nucleic acid detection with further evaluations ongoing.

Included here are:

  • a summary report for the laboratory assessments of COVID molecular diagnostic tests undertaken by PHE and completed in the period February and April 2020
  • a series of individual assay assessments

Updates to this page

Published 4 June 2020
Last updated 22 February 2021 + show all updates
  1. Added: 'Rapid assessment: BGI Real-Time Fluorescent RT-PCR kit for detecting 2019-nCoV'.

  2. Added Rapid assessment of Biomerieux ARGENE® SARS-COV-2 R-GENE® real-time detection kit.

  3. Added rapid assessment: careGENE N-CoV RT-PCR Kit.

  4. Added rapid assessments: COVID-19 Plus RealAmp kit and GenMark ePlex SARS-CoV-2 test.

  5. First published.

Sign up for emails or print this page